| Literature DB >> 16612529 |
Mariana Cardoso Guedes1, Rubens V Brito Neto, Maria Valéria S Goffi Gomez, Sandra B Giorgi Sant'Anna, Cristina G Ornelas Peralta, Arthur Menino Castilho, Ricardo Ferreira Bento.
Abstract
UNLABELLED: Cochlear implantation has been recommended for children under 24 months of age. The use of objective measures is needed to help speech processor programming. The electrically evoked compound potential (EAP), which can be assessed by neural response telemetry (NRT), is one of those objective measures. AIM: to determine how often the EAP can be recorded by NRT system during surgery and to describe the responses. STUDYEntities:
Mesh:
Year: 2006 PMID: 16612529 PMCID: PMC9442142 DOI: 10.1016/s1808-8694(15)31271-4
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Characterization of subjects.
| PATIENT | GENDER | AGE | ETIOLOGY | DURATION OF DEAFNESS (IN YEARS) | IMPLANT | INSERTION |
|---|---|---|---|---|---|---|
| 1 | M | 17 | Usher syndrome | 17 | CI24k | Complete |
| 2 | M | 39 | Meningitis | 30 | CI 11+11+2 | Complete |
| 3 | F | 9 | Meningitis | 9 | CI24k | Complete |
| 4 | M | 11 | congenital | 11 | CI24k | Complete |
| 5 | M | 40 | Otosclerosis | 14 | CI24k | Complete |
| 6 | F | 5 | congenital (maternal rubella) | 5 | CI24k | Complete |
| 7 | M | 8 | Meningitis | 6 | CI24k | Partial |
| 8 | F | 23 | progressive (genetic) | 2 | CI24k | Complete |
| 9 | M | 42 | progressive | 10 | CI24k | Complete |
| 10 | M | 12 | Meningitis | 1 | CI 11+11+2 | Partial |
| 11 | M | 30 | Ototoxicity | 5 | CI24k | Complete |
| 12 | F | 30 | Meningitis | 14 | CI24k | Complete |
| 13 | F | 42 | Meniere | 4 | CI24k | Complete |
| 14 | M | 9 | Congenital | 9 | CI24R (CS) | Complete |
| 15 | F | 2 | Meningitis | 2 | CI 11+11+2 | Partial |
| 16 | M | 5 | congenital (CMV) | 5 | CI24k | Complete |
| 17 | F | 4 | congenital (genetic) | 4 | CI24k | Complete |
| 18 | F | 3 | congenital | 3 | CI24R (CS) | Complete |
| 19 | F | 2 | congenital (leukodystrophy) | 2 | CI24k | Complete |
| 20 | F | 23 | Progressive | 2 | CI24k | Complete |
| 21 | M | 6 | Meningitis | 6 | CI 11+11+2 | Complete |
| 22 | F | 6 | congenital (prematurity) | 6 | CI24k | Complete |
| 23 | M | 5 | congenital (genetic) | 5 | CI24k | Complete |
| 24 | M | 30 | Meningitis | 10 | CI24k | Complete |
| 25 | F | 45 | Meningitis | 5 | CI24k | Partial |
| 26 | F | 30 | Meningitis | 15 | CI24k | Complete |
| 27 | M | 5 | congenital (genetic) | 5 | CI24k | Complete |
| 28 | M | 35 | Meningitis | 15 | CI 11+11+2 | Complete |
| 29 | M | 22 | Meningitis | 22 | CI24k | Complete |
| 30 | F | 40 | Meningitis | 35 | CI24k | Complete |
| 31 | F | 43 | Progressive | 2 | CI24k | Complete |
| 32 | M | 50 | Progressive | 5 | CI24k | Complete |
| 33 | M | 50 | Meningitis | 30 | CI24R (CS) | Complete |
| 34 | F | 60 | Progressive | 2 | CI24R (CS) | Complete |
| 35 | F | 43 | Progressive | 7 | CI24k | Complete |
| 36 | F | 60 | Progressive | 3 | CI24k | Complete |
| 37 | M | 38 | Otosclerosis | 2 | CI24R (CS) | Complete |
| 38 | F | 60 | progressive (genetic) | 5 | CI24k | Complete |
| 39 | M | 5 | congenital (genetic) | 5 | CI24k | Complete |
| 40 | F | 29 | Head trauma | 10 | CI24k | Complete |
| 41 | F | 60 | Otosclerosis | 10 | CI24k | Partial |
| 42 | F | 12 | Meningitis | 11 | CI24k | Complete |
| 43 | M | 55 | head trauma | 7 | CI24k | Complete |
| 44 | M | 8 | congenital | 8 | CI24k | Complete |
| 45 | F | 17 | enlarged vestibular aqueduct syndrome | 2 | CI24k | Complete |
| 46 | M | 30 | Meningitis | 30 | CI24k | Complete |
| 47 | M | 35 | Progressive | 2 | CI24k | Complete |
| 48 | M | 60 | Progressive | 5 | CI24k | Complete |
| 49 | F | 43 | Progressive | 2 | CI24k | Complete |
| 50 | F | 63 | Progressive | 14 | CI24k | Complete |
| 51 | F | 7 | congenital (jaundice) | 7 | CI24k | Complete |
| 52 | F | 9 | congenital (genetic) | 9 | CI24k | Complete |
| 53 | F | 4 | congenital (prematurity) | 4 | CI24k | Complete |
| 54 | F | 10 | congenital (maternal rubella) | 10 | CI24k | Complete |
F: female / M: male / CMV: cytomegalovirus / CI24k: model nucleus 24 kids / CI24R(CS): model nucleus 24 contour / CI 11+11+2: model nucleus 24 double array.
Graph 1Prevalence of NRT (%) based on deafness etiology.
Graph 2Prevalence of NRT (%) based on duration of deafness.
NRT thresholds and value of I/O function according to deafness etiology.
| ETIOLOGY | pNRT (mean in CU) | I/O function |
|---|---|---|
| Meningitis | 192 | 9.39 |
| Congenital Deafness | 189 | 10.9 |
| Progressive Deafness | 189 | 8.99 |
| Others (sudden causes) | 188 | 10.21 |
CU: current unit
NRT thresholds and value of I/O function according to duration of deafness.
| Duration of deafness | pNRT (mean in CU) | I/O Function |
|---|---|---|
| Up to 5 years | 189 | 11.8 |
| Between 5 and 10 years | 192 | 8.5 |
| Between 10 and 15 years | 192 | 8.9 |
| Over 15 years | 188 | 8.6 |
CU: current unit
Characteristics of NRT (thresholds, I/O function and latency) according to the position of the electrode in the cochlea.
| Apical | Medial | Basal | Total | |
|---|---|---|---|---|
| Thresholds (mean in CU) | 187 | 190 | 193 | 190 |
| Latency (mean in ms) | 0.32 | 0.34 | 0.34 | 0.33 |
| I/O function (mean) | 10.44 | 9.29 | 10.06 | 9.79 |
| Prevalence (%) | 76 | 74 | 74 | 75 |
CU: current unit